BioXcel Therapeutics Aktie
0,48
EUR
-0,05
EUR
-9,48
%
0,51
USD
-0,06
USD
-10,77
%
BioXcel Therapeutics Aktie Analyse
06.04.18 | BioXcel Therapeutics Outperform | BMO Capital Markets | |
02.04.18 | BioXcel Therapeutics overweight | Barclays Capital |